Gemini Therapeutics, Inc. GMTX

Full chart Compare
Set alert

Price alert · GMTX

All alert types
1.35 0.00 (+0.00%)

At closeDec 30, 2022, 12:00 AM EST

1.35 Day range 1.41

52-week range unavailable

Ownership

Held by insiders 0.25%
Held by institutions 87.53%
Float held by institutions 87.74%
Institutions 58

Top institutional holders

Top institutional holders
Holder% heldSharesValueReported
Orbimed Advisors LLC.13.45%5,826,2237.87MSep 29, 2022
Atlas Venture Life Science Advisors, LLC 12.13%5,254,3657.09MSep 29, 2022
Adage Capital Partners GP L.L.C.5.65%2,447,4773.30MSep 29, 2022
Foresite Capital Management V, LLC5.62%2,435,1253.29MSep 29, 2022
Foresite Capital Opportunity Management V, LLC5.62%2,435,1253.29MSep 29, 2022
Suvretta Capital Management, LLC5.48%2,372,2673.20MSep 29, 2022

Top mutual fund holders

Top mutual fund holders
Holder% heldSharesValueReported
Fidelity Select Portfolios - Biotechnology3.35%1,451,2071.96MOct 30, 2022
Vanguard Total Stock Market Index Fund0.64%275,152371.45KSep 29, 2022
Vanguard Extended Market Index Fund0.55%237,759320.97KSep 29, 2022
Fidelity Extended Market Index Fund0.36%154,315208.32KOct 30, 2022
Fidelity Growth Company Fund0.31%132,474178.84KOct 30, 2022
Bridgeway Funds Inc-Ultra Small Company Market Fund0.17%75,000101.25KSep 29, 2022
GMTX insiders
InsiderRelationLatest transactionDateShares held
FORESITE CAPITAL MANAGEMENT II, L.L.C.Beneficial Owner of more than 10% of a Class of SecurityStock Award(Grant)Feb 4, 20210
FS DEVELOPMENT HOLDINGS, L.L.C.Beneficial Owner of more than 10% of a Class of SecurityStock Award(Grant)Feb 4, 20210
LEONARD BRADEN MICHAELBeneficial Owner of more than 10% of a Class of SecuritySaleOct 25, 20225,247,500
MEYENBURG JASON PATRICKChief Executive OfficerPurchaseMay 13, 202113,000
PIEKOS BRIANChief Financial OfficerStock Award(Grant)May 30, 202217,615
TANANBAUM JAMES BDirectorStock Award(Grant)Feb 4, 20210